Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
14.78
+0.36 (2.50%)
At close: Oct 12, 2026, 4:00 PM EDT
14.71
-0.07 (-0.47%)
After-hours: Oct 12, 2026, 4:28 PM EDT
Carlsmed Revenue
Carlsmed had revenue of $18.94M in the quarter ending June 30, 2026, with 56.75% growth. This brings the company's revenue in the last twelve months to $63.30M, up 65.39% year-over-year. In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth. That makes Carlsmed the 26,144th largest company in the world by revenue and 3,602nd in the United States.
Revenue (ttm)
$63.30M
Revenue Growth
+65.39%
P/S Ratio
6.38
Revenue / Employee
$498,386
Employees
127
Market Cap
403.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CARL News
- 9 hours ago - Carlsmed price target raised to $24 from $23 at BTIG - TheFly
- 10 days ago - Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - Carlsmed appoints Jarc as Chief Product, AI Officer - TheFly
- 11 days ago - Carlsmed Appoints Tony Jarc as Chief Product and AI Officer - GlobeNewsWire
- 14 days ago - Carlsmed appoints Heppenstall as Chief Financial Officer - TheFly
- 14 days ago - Carlsmed Appoints Richard Heppenstall as Chief Financial Officer - GlobeNewsWire
- 26 days ago - Carlsmed files patent infringement lawsuit against DeGen Medical - TheFly
- 26 days ago - Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical - GlobeNewsWire